CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancerLei Nie, Mien‐Chie Hung, Li-Chuan Chan et al.|Nature Communications|2019Cited by 99
Targeting PKCδ as a Therapeutic Strategy against Heterogeneous Mechanisms of EGFR Inhibitor Resistance in EGFR-Mutant Lung CancerPei‐Chih Lee, Mien‐Chie Hung, Yueh‐Fu Fang et al.|Cancer Cell|2018Cited by 71